NovaSom Inc has collaborated with Jefferson School of Population Health to convene an expert advisory board that explored the impact of undiagnosed OSA on health care costs and productivity in the workplace.
The event brought together industry thought leaders to discuss new avenues for employers to administer OSA screening, diagnosis, and treatment for employees in an effort to manage the growing OSA epidemic within the workplace. It took place in Washington, DC on March 9, 2012.
The event convened over a dozen experts in the fields of economics, public policy, employer issues, managed care, and clinical care at organizations such as The Coca-Cola Company, GlaxoSmithKline, and the Metropolitan Transit Authority in Houston to discuss recent advancements in wireless home diagnosis and treatment technologies and business models that will allow employers to realize the benefits of proactively managing OSA.
